Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense tr...
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase, non-inferiority trial
About this item
Full title
Author / Creator
Priotto, Gerardo , Kasparian, Serena , Mutombo, Wilfried , Ngouama, Daniel , Ghorashian, Sara , Arnold, Ute , Ghabri, Salah , Baudin, Elisabeth , Buard, Vincent , Kazadi-Kyanza, Serge , Ilunga, Medard , Mutangala, Willy , Pohlig, Gabriele , Schmid, Caecilia , Karunakara, Unni , Torreele, Els and Kande, Victor
Journal title
Language
English
Formats
Subjects
More information
Scope and Contents
Contents
Human African trypanosomiasis (HAT; sleeping sickness) caused by Trypanosoma brucei gambiense is a fatal disease. Current treatment options for patients with second-stage disease are toxic, ineffective, or impractical. We assessed the efficacy and safety of nifurtimox-eflornithine combination therapy (NECT) for second-stage disease compared with th...
Alternative Titles
Full title
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase, non-inferiority trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_20182998
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20182998
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(09)61117-X
